4//SEC Filing
Newman James W. Jr. 4
Accession 0001213900-22-000067
CIK 0001513525other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 10:39 AM ET
Size
12.4 KB
Accession
0001213900-22-000067
Insider Transaction Report
Form 4
Newman James W. Jr.
Director
Transactions
- Purchase
Common Stock
2021-12-30$2.72/sh+5,000$13,600→ 50,221 total(indirect: By LLC) - Purchase
Common Stock
2021-12-30$2.66/sh+10,000$26,600→ 20,000 total
Holdings
- 34,475(indirect: By Partnership)
Common Stock
- 152,963(indirect: By LLC)
Common Stock
- 5,000(indirect: Courtney Newman)
Common Stock
- 41,160(indirect: By Trust)
Common Stock
Footnotes (8)
- [F1]The price reported in column 4 is a weighted average price. The shares were sold in multiple transaction at prices ranging from $2.628 to $2.68, inclusive. The reporting person undertakes to provide Adial Pharmaceuticals, Inc., any security holder of Adial Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (6) of this Form 4.
- [F2]James W. Newman is the general partner of Roundtop Limited Partnership, LLP.
- [F3]James W. Newman is the trustee of the Newman GST Trust FBO James W. Neman Jr.
- [F4]James W. Newman is the sole member of Virga Ventures, LLC.
- [F5]James W. Newman is the general partner of Ivy Cottage Group, LLC.
- [F6]The price reported in column 4 is a weighted average price. The shares were sold in multiple transaction at prices ranging from $2.655 to $2.72, inclusive.
- [F7]James W. Newman is the beneficiary of this Roth IRA.
- [F8]Courtney Newman is the daughter of James W. Newman, Jr.
Documents
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeother
Related Parties
1- filerCIK 0001718364
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 10:39 AM ET
- Size
- 12.4 KB